Q3 2024 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Lowered by Analyst

Biogen Inc. (NASDAQ:BIIB – Free Report) – Wedbush reduced their Q3 2024 earnings per share (EPS) estimates for shares of Biogen in a research note issued on Wednesday, April 24th. Wedbush analyst L. Chico now anticipates that the biotechnology company will earn $4.02 per share for the quarter, down from their prior estimate of $4.13. […]

Leave a Reply

Your email address will not be published.

Previous post Boston Herald boys swimming All-Scholastics and league All-Stars
Next post Advanced Micro Devices (NASDAQ:AMD) PT Lowered to $185.00